LegisTrack
Back to all bills
HRES 675119th CongressIn Committee

Expressing support for the designation of September 2025 as "National Prostate Cancer Awareness Month".

Introduced: Sep 3, 2025
Sponsor: Rep. Carter, Troy A. [D-LA-2] (D-Louisiana)
Healthcare
Standard Summary
Comprehensive overview in 1-2 paragraphs

H. Res. 675 is a non-binding resolution introduced in the House expressing support for designating September 2025 as National Prostate Cancer Awareness Month. It uses a series of “Whereas” statements to lay out the scope of the issue—demographics, risk factors, and the importance of screening (digital rectal examinations and prostate-specific antigen tests)—and to emphasize the impact of prostate cancer on men and families. The resolution then says the House should recognize the designation and take steps to raise awareness, encourage research into improved screening, treatment, causes, and a cure, and to consider ways to improve access to quality health care for detecting and treating the disease. It also invites the public and stakeholder groups to promote awareness and observe the month with ceremonies and activities. In essence, this is a symbolic measure aimed at increasing public awareness and supporting ongoing efforts in prevention, detection, and treatment.

Key Points

  • 1The House expresses support for designating September 2025 as National Prostate Cancer Awareness Month.
  • 2It calls for increased awareness about the importance of screening methods (such as digital rectal exams and PSA blood tests) and treatment options for prostate cancer.
  • 3It urges ongoing and enhanced research to improve screening and treatment, to discover causes, and to develop a cure.
  • 4It encourages improving access to and the quality of health care services for detecting and treating prostate cancer.
  • 5It asks the public, interest groups, and those affected to promote awareness and observe the month with appropriate ceremonies and activities.

Impact Areas

Primary group/area affected: Men at risk or diagnosed with prostate cancer and their families; health care providers who screen and treat the disease.Secondary group/area affected: Veterans (reference to VA Precision Oncology Centers of Excellence) and researchers focused on cancer prevention, detection, and treatment.Additional impacts: This is a symbolic, non-binding resolution with no new funding or mandatory requirements; its effect is to boost awareness, encourage education and outreach, and potentially influence supportive activities and partnerships around National Prostate Cancer Awareness Month.
Generated by gpt-5-nano on Oct 8, 2025